IRIS
FRONTONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.932
AS - Asia 2.616
EU - Europa 2.246
SA - Sud America 330
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 33.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.879
SG - Singapore 1.510
CN - Cina 463
UA - Ucraina 384
DE - Germania 383
BR - Brasile 288
IE - Irlanda 286
IT - Italia 282
HK - Hong Kong 265
RU - Federazione Russa 181
SE - Svezia 181
GB - Regno Unito 157
FR - Francia 103
VN - Vietnam 102
FI - Finlandia 86
PL - Polonia 80
KR - Corea 77
IN - India 32
JP - Giappone 31
NL - Olanda 28
CA - Canada 27
ID - Indonesia 25
TR - Turchia 25
AR - Argentina 23
AT - Austria 19
MX - Messico 18
BD - Bangladesh 16
ES - Italia 15
ZA - Sudafrica 13
BE - Belgio 12
CZ - Repubblica Ceca 11
EU - Europa 10
IQ - Iraq 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
UZ - Uzbekistan 8
AU - Australia 6
KG - Kirghizistan 6
PK - Pakistan 6
EC - Ecuador 5
CH - Svizzera 4
IL - Israele 4
KE - Kenya 4
VE - Venezuela 4
AL - Albania 3
AO - Angola 3
CO - Colombia 3
DK - Danimarca 3
EG - Egitto 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
TW - Taiwan 3
TZ - Tanzania 3
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 33.181
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.791
Wilmington 7.439
Houston 6.469
Fairfield 946
Singapore 655
Ann Arbor 623
Chandler 579
Ashburn 545
Seattle 338
Jacksonville 330
Cambridge 297
Hong Kong 264
Dublin 258
Beijing 221
Medford 202
Dearborn 186
New York 115
Santa Clara 110
Los Angeles 100
Lawrence 91
The Dalles 78
Rome 75
Kraków 61
Buffalo 58
Dallas 49
Menlo Park 38
Council Bluffs 37
Mülheim 35
São Paulo 33
Nuremberg 32
San Diego 32
Milan 29
Boardman 28
Munich 28
Falls Church 27
Moscow 24
Tokyo 24
Hanoi 23
Ho Chi Minh City 22
London 22
Palo Alto 22
Nanjing 20
Redwood City 19
San Jose 19
Zhengzhou 19
Norwalk 18
Phoenix 18
Boston 17
Jakarta 17
Mountain View 17
San Mateo 17
Dong Ket 16
Guangzhou 16
Warsaw 16
Brooklyn 15
Columbus 14
Redondo Beach 14
Chicago 13
Verona 13
Brussels 12
Chengdu 12
Helsinki 12
Kunming 12
Nürnberg 12
Orem 12
Shanghai 12
Brno 11
Chennai 11
Atlanta 10
Indiana 10
Montreal 10
San Francisco 10
Ankara 9
Haiphong 9
Hefei 9
Stockholm 9
University Park 9
Hangzhou 8
Johannesburg 8
Seoul 8
Toronto 8
Auburn Hills 7
Belo Horizonte 7
Creede 7
Detroit 7
Frankfurt am Main 7
Mexico City 7
Poplar 7
Rio de Janeiro 7
Brasília 6
Campinas 6
Manchester 6
Nanchang 6
Saint Petersburg 6
Cangzhou 5
São Bernardo do Campo 5
Tremestieri Etneo 5
Trieste 5
Turin 5
Vienna 5
Totale 28.973
Salva come PNG Salva come JPEG
Nome #
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 543
Insulin clearance is associated with carotid artery intima-media thickness 538
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 501
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients 492
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 476
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 468
The social burden of hypoglycemia in the elderly 464
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 460
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 457
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 454
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 454
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 453
Preliminary evidence that obese patients with obstructive sleep apnea/hypopnea syndrome are refractory to the acute beneficial metabolic effects of a very low calorie diet 453
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 452
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 443
Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes 439
Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients 438
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases [Linee Guida per la concessione dell'idoneità all'attività sportiva ed il monitoraggio degli atleti affetti da malattie del sistema endocrino] 430
Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes 429
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 429
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 429
Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379. 424
Carbohydrate metabolism in hypertension: influence of treatment 424
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 424
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability 418
Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes 415
The DAWN Youth WebTalk Study: methods, findings, and implications. 415
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 413
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 411
Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. 409
Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats 406
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes 405
Methods of investigation for cardiac autonomic dysfunction in human research studies 404
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C 404
Hyperinsulinaemia in offspring of Type 2 diabetic patients: impaired response of carbohydrate metabolism, but preserved cardiovascular response 403
Acute hyperglycemia reduces cerebrovascular reactivity: The role of glycemic variability 399
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 396
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients 395
Evaluation of guidelines on diabetes medication. 395
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 394
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database 390
Single retinal layer evaluation in patients with type 1 diabetes with no or early signs of diabetic retinopathy: The first hint of neurovascular crosstalk damage between neurons and capillaries? 390
SYMPTOMATIC TREATMENT OF AUTONOMIC NEUROPATHY IN DIABETIC SUBJECTS 388
Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. 386
Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. 382
Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease 382
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint 382
Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography 382
The need for identifying standardized indices for measuring glucose variability. 380
Glucose variability: An emerging target for the treatment of diabetes mellitus 377
Bariatric surgery or medical therapy for obesity 374
Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit. 369
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 368
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 367
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 364
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 363
Effect of the GSTM1 gene deletion on glycemic variability, sympatho-vagal balance and arterial stiffness in patients with metabolic syndrome, but without diabetes 363
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 355
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases 355
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women 351
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 351
Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? 350
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes 347
QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA 347
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 347
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. 337
Correspondence between the international diabetes federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic caucasians: The GISIR database [4] 334
Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus 324
Effects of insulin on cholesterol synthesis in type II diabetes patients 323
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 316
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 316
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels 310
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes 305
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 297
La terapia insulinica aumenta il rischio cardiovascolare? 295
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 293
Flavonoids and insulin-resistance: from molecular evidences to clinical trials 265
Activation of retinal Müller cells in response to glucose variability 258
Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome 256
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 250
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 249
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 240
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 239
Neuropathic damage in the diabetic eye: clinical implications 193
Early alterations of corneal subbasal plexus in uncomplicated type 1 diabetes patients 184
Urban diabetes: the case of the metropolitan area of Rome 174
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 121
Urban diabetes: the case of the metropolitan area of Rome 121
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery 84
Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System 81
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes 80
Glycemic status assessment by the latest glucose monitoring technologies 76
The evaluation of tactile dysfunction in the hand in type 1 diabetes: a novel method based on haptics 69
Subcutaneous insulin infusion (CSII) in italy: The third national survey 63
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 60
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance 58
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 56
Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-determination: the Italian Road to Bariatric Surgery 52
Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations 49
Knowledge, experiences, and perceptions relating to obesity management among primary care physicians in the Lazio Region, Italy 35
Totale 33.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.046 0 0 0 0 0 493 584 466 127 107 180 89
2021/20221.009 38 106 75 46 52 105 44 55 47 93 53 295
2022/20231.406 137 107 68 186 150 298 123 80 149 3 65 40
2023/2024361 38 12 29 12 39 111 27 17 6 9 5 56
2024/20252.453 104 510 251 131 53 105 200 112 199 137 324 327
2025/20261.672 338 199 465 286 286 98 0 0 0 0 0 0
Totale 33.429